Middle-aged Patients

Middle-aged patients are adults in the middle portion of the lifespan, commonly described as approximately 40 to 65 years old, although clinical definitions vary. Medical care for this group accounts for gradual physiological changes, accumulated risk factors, family history, lifestyle, and the presence of chronic conditions that can influence symptoms, treatment response, and disease risk. Assessment typically combines medical history, physical examination, preventive screening, and evaluation of cardiovascular, metabolic, and mental health. Understanding these factors supports earlier detection, individualized treatment plans, and prevention of complications while helping clinicians address changing health needs across the transition to older adulthood.

Middle-aged Patients - Related Videos

Education

JoVE Core - Pharmacokinetics and Pharmacodynamics

Pharmacodynamics in Geriatric Patients: Effects of Age

0 Views •

2025

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Research

JoVE Journal - Neuroscience
Free Sample

Kinematics and Ground Reaction Force Determination: A Demonstration Quantifying Locomotor Abilities of Young Adult, Middle-aged, and Geriatric Rats

0 Views •

Cited by 26 •

2011

Locomotion is often examined as a behavioural outcome in various models of disease in fields such as neuroscience and orthopedics. This video paper intends to describe a method for collecting ground reaction forces and kinematics from rats during unrestrained locomotion.

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

0 Views •

2025

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

0 Views •

2025

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

0 Views •

2025

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

View All Results

FAQs

Related Topics